Radhika Madhavan1, Suresh Emmanuel Joel1, Saikat Saha1, Marisa DiMarziio2, Eric Fiveland3, Jeffrey Ashe3, Michael Gillogly4, Jennifer Durphy4, Julia Prusik2,4, Pilitsis Julie2,4, and Ileana Hancu3
1GE Global Research, Bangalore, India, 2Department of Neuroscience and Experimental Therapeutics, Albany Medical Center, Albany, NY, United States, 3GE Global Research, Niskayuna, NY, United States, 4Department of Neurosurgery, Albany Medical Center, Albany, NY, United States
Synopsis
Deep Brain Stimulation is an
effective treatment for Parkinson's disease symptoms. Despite its success, the underlying principle and the mechanisms are not yet fully understood. In this
study, we recorded concurrent DBS-fMRI to 1) elucidate brain regions activated at
the clinically optimal settings and, 2) determine
the effect of changes in stimulation frequency on whole-brain activation.
Optimal DBS frequencies showed activation in the thalamus and motor cortices.
Further, there was a significant difference in activation in the sensorimotor
cortices between the optimal and non-optimal frequencies, indicating potential
use for fMRI as a tool for optimizing DBS parameters.
Introduction
Deep brain stimulation (DBS) is a functional treatment that is widely accepted as a therapy for Parkinson’s
disease (PD)1,2. Despite its remarkable
clinical success, the precise mechanism of action remains to be elucidated. Most electrophysiological and cellular studies3, have investigated the local effects of DBS.
However, visualization and understanding whole-brain effects of DBS requires
functional imaging techniques, such as functional Magnetic Resonance Imaging
(fMRI)4,5. Existing methods for tuning
DBS parameters are largely based on trial and error, requiring at
least 6-months of iterative search for the parameter combination that best
mitigates symptoms. An understanding of whole-brain effects of DBS can
significantly reduce programming time. In this study, we aim to use fMRI to 1)
identify DBS-activated brain regions in PD patients with optimized DBS settings
and, 2) investigate how frequency changes impacts brain response.Methods
PD subjects implanted with DBS electrodes in either the sub-thalamic nucleus (STN) or globus pallidus internal (GPi) were recruited for this study, and underwent concurrent DBS and fMRI. A total of 11 subjects were
included in this study: 5/1 bilateral STN/GPi, 3/2 unilateral STN/GPi. After
a T1-weighted anatomical acquisition, all patients were set on a 30s DBS ON/30s
DBS OFF cycling paradigm. fMRI was acquired on a 1.5 T (GE Healthcare) MR scanner
for 6-minutes using whole brain GE-EPI at a spatial resolution of 3.75 x 3.75 x
3mm, with a TE/TR of 45/3011ms. fMRI
cycling and stimulation were synchronized using an electronic synchronization box6. Each patient underwent one scan at their
clinically optimized settings and 2-4 scans at clinically non-optimal frequency
settings (60-220Hz).
fMRI data were slice time corrected, motion
corrected, rigid registered to T1-weighted image, non-rigid registered to
Montreal Neurological Institute atlas, spatially smoothed using FWHM 6mm using SPM12
(http://www.fil.ion.ucl.ac.uk/). Functional activation maps (t-maps) were estimated
using 30s ON/OFF block design at a voxel level. Response maps were thresholded
at p<0.05 (cluster threshold 50 with p<0.001) for visualization.
Results
The
fMRI response maps were different for optimal and non-optimal frequency
settings (Fig. 1). Group-level analysis for all patients at optimal frequency
settings showed activation in bilateral
thalamus, motor cortex and posterior cerebellum; and deactivation in secondary
visual and inferior frontal cortices (Fig. 1a), consistent with previous literature4,7. In contrast, the non-optimal frequency settings showed deactivation in
the right motor cortex (Fig. 1b). Across subjects, the motor cortex showed
significantly greater activation in optimal compared to non-optimal frequency
settings (p<0.05, Fig. 1c). To
alleviate the variability due to differences in electrode locations and
laterality, we calculated response maps for only the 5 bilateral STN patients.
The results were similar with stronger t-values.
Mean t-values were
calculated for 16 regions-of interest including the thalamus, pallidum,
sensorimotor cortex, anterior and posterior cerebellum, primary and secondary
visual areas and operculum. While optimal frequencies
in our cohort ranged from [60-220Hz] in order to enable group-level analysis,
each patient’s frequencies were mapped to a scale relative to the optimal
frequency, which was set to 0 (Fig. 2). Thalamus, pallidum and anterior
cerebellar regions showed significantly stronger activation in optimal compared
to non-optimal frequencies (p<0.05,
rank sum test, Fig. 2a-c). Sensorimotor cortex and posterior cerebellum showed
significantly stronger deactivation for optimal compared to non-optimal
frequencies (p<0.05, rank sum
test, Fig. 2d-f). Absolute frequencies (not relative as shown in Fig. 2) were significantly
correlated to activation in regions of the thalamo-cortical motor circuit (Fig.
3).
Discussion and conclusions
We
have successfully conducted concurrent fMRI in PD patients with DBS implants. The
stimulation frequency was varied around the clinically optimal configuration to
determine the effect this parameter on brain activation. The pattern of
activation and deactivation was significantly different between optimal and
non-optimal frequencies; more specifically, in the sensorimotor regions (Fig.
1). At the optimal frequency, the activation/deactivation was maximal in
regions of the thalamo-cortical motor circuit, decreasing sharply at
non-optimal frequencies (Fig. 2). As shown previously8, frequency changes were positively
correlated with amount of energy delivered locally, potentially associated with
the amount of activation in the volume of tissue around the electrode. Increased
activation at optimal frequency cannot be attributed to the absolute frequency,
because though frequency was correlated to activation amplitude, optimal
frequency was found to be uniformly distributed across the entire range of
frequencies (Fig. 2-3). Here, we demonstrate that fMRI
can be used to optimize DBS frequency. This can be expanded to other DBS
parameters (voltage, contact, pulse-width), allowing the clinician to rapidly
tune DBS for best symptom relief in PD and improve the customization of DBS to
individual patients.Acknowledgements
No acknowledgement found.References
- Okun, M. S. Deep-brain stimulation for
Parkinson’s disease. N. Engl. J. Med. 367, 1529–1538 (2012).
- Kringelbach, M. L., Jenkinson, N., Owen, S. L. F. &
Aziz, T. Z. Translational principles of deep brain stimulation. Nat. Rev.
Neurosci. 8, 623–635 (2007).
- McIntyre, C. C. & Hahn, P. J. Network Perspectives on
the Mechanisms of Deep Brain Stimulation. Neurobiol. Dis. 38,
329–337 (2010).
- Kahan, J. et al. Therapeutic Subthalamic Nucleus Deep
Brain Stimulation Reverses Cortico-Thalamic Coupling during Voluntary Movements
in Parkinson’s Disease. PLOS ONE 7, e50270 (2012).
- Phillips, M. D. et al. Parkinson disease: pattern of
functional MR imaging activation during deep brain stimulation of subthalamic
nucleus--initial experience. Radiology 239, 209–216 (2006).
-
Fiveland, E. et al. EKG-based detection of deep brain
stimulation in fMRI studies. Magn. Reson. Med. (2017).
doi:10.1002/mrm.26868
-
Albaugh, D. L. & Shih, Y.-Y. I. Neural Circuit
Modulation During Deep Brain Stimulation at the Subthalamic Nucleus for
Parkinson’s Disease: What Have We Learned from Neuroimaging Studies? Brain
Connect. 4, 1–14 (2013).
-
Koss, A. M., Alterman, R. L., Tagliati, M. & Shils, J.
L. Calculating total electrical energy delivered by deep brain stimulation
systems. Ann. Neurol. 58, 168; author reply 168-169 (2005).